Meropenem Hikma

Meropenem, the active ingredient in Meropenem Hikma, is a carbapenem antibiotic presented as a sterile powder for intravenous use. It provides broad‑spectrum bactericidal activity for the treatment of serious infections in hospitalized patients. GNH USA supplies Meropenem Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem antibiotic used to treat serious bacterial infections.

Complicated intra‑abdominal infections: provides rapid bactericidal activity against mixed aerobic and anaerobic pathogens. Complicated urinary tract infections: eradicates resistant Gram‑negative organisms causing pyelonephritis. Skin and soft tissue infections: treats severe cellulitis and necrotizing infections. Community‑acquired and hospital‑acquired pneumonia: covers typical and atypical respiratory pathogens. Meningitis: penetrates the cerebrospinal fluid to eliminate causative bacteria. Severe sepsis: offers immediate bacterial clearance in systemic infections.

Common Side Effects: - Nausea or vomiting - Diarrhea, including mild colitis - Rash or pruritus at the infusion site - Headache or dizziness - Elevated liver enzymes (AST/ALT) - Phlebitis or irritation at the intravenous site

Serious or Rare Side Effects: - Clostridioides difficile‑associated colitis - Anaphylactic or severe hypersensitivity reactions - Seizures, especially in patients with CNS disorders - Acute renal impairment or worsening kidney function - Thrombocytopenia or other hematologic abnormalities - Severe skin reactions such as Stevens‑Johnson syndrome

Meropenem should be used with careful clinical monitoring. - Renal function: assess creatinine clearance and adjust dose in renal impairment. - Hypersensitivity: avoid in patients with known carbapenem or beta‑lactam allergy. - CNS disorders: monitor for seizures, particularly in patients with a history of epilepsy. - C. difficile risk: watch for signs of severe diarrhea and colitis. - Concomitant nephrotoxic agents: use cautiously with other renal‑toxic drugs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with several medications.

Major Interactions (Avoid): - Valproic acid: concomitant use can reduce valproate levels and precipitate seizures. - Other carbapenems: combined use may increase toxicity without added benefit. - High‑dose aminoglycosides: additive nephrotoxicity risk.

Moderate Interactions (Monitor Closely): - Loop diuretics: may enhance renal effects, requiring renal function monitoring. - Warfarin: potential alteration of INR, necessitating coagulation monitoring. - Phenobarbital or phenytoin: may lower meropenem concentrations, adjust therapy as needed.